- A groundbreaking new study brings scientists one step closer to preventing age-related cognitive decline
- Hyperbaric Oxygen Therapy (HBOT) holds promise for new medicinal approach to Alzheimer’s by targeting the core biological indicators responsible for the development of the disease
- Gulf countries including UAE, Saudi Arabia, Kuwait and Qatar can anticipate an increase in the possible number of people who may be susceptible to developing Alzheimer’s disease due to the growing population
- a comprehensive program based on HBOT therapy is currently available in Aviv’s flagship clinic in Dubai
Dubai, United Arab Emirates: Aviv Clinics recently published a landmark study that proves – for the first time; the effectiveness of using a unique protocol of Hyperbaric Oxygen Therapy (HBOT) in reversing early indicators that could lead to the development of Alzheimer’s disease.
Hyperbaric Oxygen therapy (HBOT) is a non-pharmaceutical, non-invasive method that involves administering patients with a hundred per cent pure oxygen in a pressurized environment to accelerate normal organ function and tissue repair. The treatment has been used for decades to treat other medical conditions, and this study now shows the promise of HBOT as a potential treatment to reverse main activators behind developing early symptoms of Alzheimer’s and dementia and treat brain and cognitive problems such as memory loss.
The research revealed that hyperbaric oxygen treatment, led to improvement in the blood flow, blood vessels and as a result increase the performance of the brain and body functionality of elderly patients’
Aviv has developed a unique medical program that includes the same HBOT protocol as used in the study, in addition to cognitive and physical training plans, and nutritional coaching, to enhance brain and body performance of aging adults.
Aviv’s flagship clinic in Dubai is equipped with the world’s largest HBOT chambers in terms of capacity, offering patients accessibility to this transformative treatment in a premium facility and a high-end experience & service.
“The brain is an incredibly complex organism home to a network of nerve cells that depend on oxygen to thrive. As we age, the number of blood vessels in the brain naturally begins to decline, leading to memory loss and deterioration of other mental functions” said Dr. Shai Efrati, Chairman of the medical advisory board to Aviv Clinics.
Statistics indicate that most countries in the GCC have a predominantly young population. Research has recently found that some countries in the Gulf such as UAE, Saudi Arabia, Kuwait and Qatar can anticipate a significant increase up to fivefold in their older population. This shift in the country’s population demographic can result in an increase in the possible number of people who may be susceptible to developing Alzheimer’s disease.
“The study gives us hope that HBOT can be used as a viable drug-free and non-invasive method to prevent and treat early stages of Alzheimer’s disease. We are pleased to be able to offer patients in the UAE and the neighboring regions access to our breakthrough medical treatment that treats the decline in age related cognitive and physical performance right here at our Clinic in the heart of Dubai.” said Mike Frayne, Chief Executive Officer, Aviv Clinics Dubai.
“By treating vascular dysfunction, we’re mapping out the path toward Alzheimer’s prevention. More research is underway to further demonstrate how HBOT can improve cognitive function and become an influential tool in the imperative fight against the disease,” affirms Dr. Shai Efrati.
Alzheimer’s disease is the most common form of dementia and is often associated with the build-up of a protein called amyloid-beta. It is a degenerative brain condition that destroys memory and a patient’s cognitive skills. The most advanced stages of Alzheimer’s eventually hinder patients from the ability to do simple tasks. Signs of Alzheimer’s usually appear when a person is in their mid-60’s.
The study was published earlier in September in Aging, a US peer-review medical journal as part of an ongoing program that is geared towards researching age related cognitive decline. previews studies already proved that this HBOT protocol can improve cognitive performance and reverse some biological aspects related to the aging process
- The comprehensive research, conducted at the Sagol School of Neuroscience at Tel Aviv University and the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, was led by study co-authors:
o Professor Shai Efrati, M.D.; Professor Uri Ashery, Ph.D.
o Ronit Shapira, Ph.D.; Pablo Blinder, Ph.D.
o Amir Hadanny, M.D.
- Using combined data from an animal model of Alzheimer’s, where effects were evaluated directly on brain tissue (Sagol School of Neuroscience at Tel Aviv University); humans, assessed with the use of high-resolution MRI and computerized cognitive test (Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center); correlating results displayed beneficial effects of HBOT on patients suffering from mild cognitive impairment (MCI), the stage before dementia.
- Aviv has developed a unique medical treatment protocol that includes HBOT, cognitive and physical training, and nutritional coaching, to enhance brain and body performance of aging adults at Aviv Clinics, currently available in Central Florida and Dubai.
- Each patient received a unique HBOT protocol, showcasing substantial improvement in cognitive functions – with memory, attention, focus, and information processing speed exhibiting the strongest results.
- Vascular dysfunction which refers to the decrease of blood flow in the brain, is a crucial element in the development of Alzheimer’s and cognitive decline:
- Amyloid beta deposits in the brain blood vessel walls are the most common vascular pathology in Alzheimer’s.
- Reduced blood flow to the brain and its related decrease in oxygen supply (hypoxia) can precede the clinical onset of dementia and correlates with the degree of cognitive impairment in Alzheimer’s.
Additional quotes:
Professor Uri Ashery: “After dedicating our HBOT research to exploring its impact on the areas of brain functionality and age-related cognitive decline, we have discovered for the first time HBOT induces degradation and clearance of pre-existing amyloid plaques – treatment, and the appearance of newly formed plaques- prevention. Elderly patients suffering from significant memory loss at baseline revealed an increase in brain blood flow and improvement in cognitive performance, demonstrating HBOT potency to reverse core elements responsible for the development of Alzheimer’s disease.”
Aviv Clinics:
Aviv Clinics is the leader in the research and treatment of age-related cognitive and functional decline and novel applications of hyperbaric oxygen therapy (HBOT) to maximize human performance. Based on an exclusive partnership with the world’s largest hyperbaric medicine and research facility, the Sagol Center at Shamir Medical Center in Israel, Aviv is introducing a global network of clinics delivering the most effective evidence-based treatment of the aging process – the Aviv Medical Program. The three-month regimen designed to improve the aging process in healthy adults was developed on over a decade of research and more than 1,000 patients treated worldwide under the scientific leadership of Shai Efrati, M.D., Chair of Aviv Scientific’s Medical Advisory Board and Director of the Sagol Center.
